Herpes Vaccine Clinical Trial
source link: https://thetechwires.com/news/biontech-delivers-first-patient-dose-in-herpes-vaccine-clinical-trial/
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
BioNTech Delivers First Patient Dose in Herpes Vaccine Clinical Trial
BioNTech has finally dosed the first patient with its Herpes Vaccine (BNT163) in a candidate clinical trial. According to the German Vaccine maker, “The vaccine is designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research study.”
The aim of the candidate vaccine is meant to prevent HSV-2, the herpes simplex virus that causes genital herpes, and most possibly the HSV-1, which causes oral herpes which leads to genital herpes.
This vaccine is the first result of a research collaboration that was established in 2018 between the University of Pennsylvania and BioNTech. They’re aimed at developing novel mRNA vaccine candidates for the prevention and treatment of several infectious diseases.
According to data from WHO, the number of people aged between 15-29, that are suffering from HSV-2 infection globally are around 491 million.
For their candidate clinical trial, BioNTech has enrolled 100 people aged 18-55 for the phase 1 trial of the vaccine.
Recommend
-
8
Novel HIV vaccine approach shows promise in “landmark” first-in-human trialThe vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV and various other...
-
11
April 5, 2021 Four ways concomitant medications can complicate your clinical trial By: Craig Morgan
-
6
HIV Vaccine Trial Starts at Oxford Become a fan of Slashdot on Facebook ...
-
13
Covid-vaccine scientists begin plague-jab trialPublished24 minutes agoRelated TopicsCoronavirus pandemic...
-
9
Pfizer launches mRNA flu vaccine trial Issued on: 27/09/2021 - 23:28 ...
-
8
Surprise, surprise — Ivermectin worthless against COVID in largest clinical trial to date The antiparasitic failed to reduce hospitalization and all other severe outcomes.
-
7
AdvertisementHealthA Nasal Spray Seems to Help Clear Coronavirus in Clinical TrialThe spray has already b...
-
10
Blowing it — Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab The trial used the same vaccine formula as the AstraZeneca vaccine given intramu...
-
7
fingers crossed — Long-sought universal flu vaccine: mRNA-based candidate enters clinical trial The phase I trial will test safety and efficacy in a small number of people....
-
3
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK